1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Dr. Peter Mueller has been named an honored member in science by Princeton Premier.

Dr. Peter Mueller, executive vice president of drug innovation and realization and chief scientific officer of Vertex Pharmaceuticals, Inc, has been chosen for inclusion in the 2008-2009 Princeton Premier Registry.

 
PRLog - Aug. 8, 2008 - Dr. Peter Mueller is the executive vice president of drug innovation and realization and chief scientific officer of Vertex Pharmaceuticals, Inc., a biotechnology company with activities spanning the length of the pharmaceutical product pipeline, from target identification through to clinical trials and marketing.  Dr. Mueller has served in these appointments since February 2006 and is responsible for all research and drug discovery operations, pharmaceutical development (CMC), quality assurance and analysis of all Vertex product candidates.  His expertise spans two decades and includes proficiency in the areas of drug development, immunology and chemistry.  Prior to joining Vertex, Dr. Mueller was the senior vice president of research and development for Boehringer Ingelheim Pharmaceuticals, Inc., where his responsibilities included the development of all drug candidates within the company’s worldwide portfolio.  He also led research programs in the areas of immunology, inflammatory cardiovascular disease and gene therapy and provided medicinal chemistry management. Dr. Mueller received an undergraduate degree and a Ph.D. in chemistry from the Albert Einstein University of Ulm, Germany, where he also holds a professorship in theoretic organic chemistry. He completed fellowships in quantum pharmacology at Oxford University and in biophysics at Rochester University.  At home in Cambridge, Massachusetts, Dr. Mueller enjoys reading nature and science journals as well as scuba diving, mountain climbing and playing piano.  

In recognition of an outstanding career as executive vice president of drug innovation and realization and chief scientific officer of Vertex Pharmaceuticals, Inc, Dr. Peter Mueller is being included in the 2008/2009 Princeton Premier Registry where he will be listed among the most accomplished business leaders and professionals from every industry around the globe.

# # #

Princeton Premier is a publisher of an exclusive registry of business leaders & professionals making an impact in industry and community. The online network is a large interactive community where members use the web based service to meet business goals.

--- End ---

Click to Share

Contact Email:
Source:Princeton Premier
Phone:1-888-767-7548
Zip:11105
State/Province:New York - United States
Industry:Science
Shortcut:prlog.org/10101602
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share